Eikon Therapeutics
Eikon Therapeutics is a late-stage clinical biopharmaceutical company developing cancer therapies through immune response modulation and synthetic lethality. Founded in 2019 and based in Millbrae, California, it has raised $1.1 billion in funding and employs 436 people.
The growth story
Eikon Therapeutics grew from 67 to 436 employees between 2021 and 2026, raising $1.1B along the way, most recently a Series D in February 2025.
About
Eikon Therapeutics focuses on advancing novel therapies for unmet medical needs, particularly in oncology. Its clinical programs aim to improve cancer treatment by leveraging immune response modulation and synthetic lethality, while its discovery efforts target novel therapeutic pathways through single-molecule analysis.
The company has rapidly scaled since its 2019 founding, reaching a headcount of 436 and securing $1.1 billion in funding, including a Series D round in February 2025. Its substantial funding and late-stage clinical focus position it as a significant player in biopharmaceutical innovation.
Founders and leadership
Eikon Therapeutics is led by a team focused on advancing novel therapies, with research being the largest function, accounting for 45% of the workforce. The company operates with a median tenure of 2 years, reflecting its rapid growth and dynamic environment.
The Eikon Therapeutics org chart
Roger M. Perlmutter (Chairman, President, and CEO) leads 59 mapped leaders with 6 direct reports. Click +N to expand a team; names link to the person’s public profile.
Departments, and which ones grew
Headcount by function: Research 161 (+13% YoY), Engineering 57 (+4% YoY), Operations 38 (+9% YoY), Information Technology 26 (-10% YoY), Business Development 23 (-12% YoY), Healthcare Services 19 (+19% YoY).
Talent flow
Eikon Therapeutics draws heavily from major pharmaceutical companies, with Merck, Amgen, Gilead Sciences, Pfizer, Genentech, and Novartis being the top talent sources. Alumni often move to companies like BridgeBio and Revolution Medicines or return to academia, such as the University of California, Berkeley.
Most common previous employers of Eikon Therapeutics staff: Merck (25), Amgen (17), Gilead Sciences (16), Pfizer (16), Genentech (16), Novartis (16). Former Eikon Therapeutics employees most often moved to BridgeBio (5), Revolution Medicines (4), University of California, Berkeley (3), Guardant Health (2), Genentech (2), TuneIn (2).
Alumni worth knowing
Hiring now
Web traffic
Traffic mix: 31% direct, 62% search, 2% social, 0% paid.
What this company is made of
Most common skills at Eikon Therapeutics: Project Management (120), Microsoft Office (107), Research Skills (104), Leadership (102), Data Analysis (96), Microsoft Excel (90), Biotechnology (86), Clinical Trials (84).
Where the team actually sits
Eikon Therapeutics people are concentrated in California, United States (91), San Francisco Bay Area (48), New York City Metropolitan Area (26), United States (21). 2 offices on record.
Search footprint
Eikon Therapeutics attracts about 1,348 organic search visits a month, traffic worth roughly $12K a month if bought through ads. It gained 93 ranking keywords and lost 51 in the last period.
What employees say
- Compensation
- 3.30 / 5
- Career opportunities
- 2.80 / 5
- Senior management
- 2.70 / 5
- Work-life balance
- 3.10 / 5
Frequently asked
Eikon Therapeutics has 436 employees as of September 2026.
Eikon Therapeutics has raised $1.1B in total, most recently a Series D round in February 2025.
Roger M. Perlmutter (Chairman, President, and CEO) sits at the top of Eikon Therapeutics's reporting structure, with 6 direct reports.
The most common previous employers of current Eikon Therapeutics staff are Merck (25 people), Amgen (17 people), Gilead Sciences (16 people).
Former Eikon Therapeutics employees most often move to BridgeBio (5), Revolution Medicines (4), University of California, Berkeley (3).
Eikon Therapeutics attracts about 1,348 organic search visits a month, worth roughly $12K a month in equivalent ad spend.
The most common skills among Eikon Therapeutics staff are Project Management, Microsoft Office, Research Skills, Leadership, Data Analysis.
Eikon Therapeutics staff are concentrated in California, United States (91), San Francisco Bay Area (48), New York City Metropolitan Area (26).
Eikon Therapeutics has about 161 people in Research, up 13% over the past year, as of September 2026.
Eikon Therapeutics has about 57 people in Engineering, up 4% over the past year, as of September 2026.
Computed from 247 current and 199 former Eikon Therapeutics profiles, as of September 2026. Source: Crustdata.
Build this for any company
Every number on this page came from the Crustdata API. Point the MCP at a company and get the same org chart, alumni list and talent flow in one prompt.